CLASS III Drug recall · Reported 18 Jul 2018 · FDA Enforcement Report

Enalapril Maleate Tablets recalled by Wockhardt

Wockhardt is recalling Enalapril Maleate Tablets USP, distributed nationwide in the US. The recall was initiated on 19 Jun 2018 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesBatch# DR10445 (Exp: 4/19); Batch# DR10637 (Exp: 5/19); Batch# DR10646 (Exp: 5/19); Batch# DR10647 (Exp: 5/19); Batch# DR10725 (Exp: 7/19); Batch# DR10755 (Exp: 7/19); Batch# DR10811 (Exp: 9/19); Batch# DS10040 (Exp: 12/19); Batch# DS10041 (Exp: 12/19); Batch# DS10024 (Exp: 12/19); and Batch# DS10048 (Exp: 12/19).
Quantity recalled31,710 tablets

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0912-2018
FDA event ID
80356
Recalling firm
Wockhardt, Karodi
Classification
Class III
Status
Terminated
Recall initiated
19 Jun 2018
FDA classified
9 Jul 2018
Reported
18 Jul 2018
Reason category
Potency & Assay

Timeline

19 Jun 2018Recall initiated by company
9 Jul 2018Classified by FDA+20 days
18 Jul 2018Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Failed Impurities/Degradation Specifications

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Enalapril Maleate Tablets USP; 5 mg NDC code 64679-924-03. 1000 Tablets HDPE container pack with Non CRC cap and 2 desiccants further packed in E-flute cartons.

Where it was distributed

Nationwide.

Nationwide

Questions about this recall

Is Enalapril Maleate Tablets USP recalled?

Yes. Wockhardt recalled Enalapril Maleate Tablets USP on 19 Jun 2018. The recall is Class III and its status is Terminated. Recall number D-0912-2018.

Why was it recalled?

Failed Impurities/Degradation Specifications

Which lots are affected?

Batch# DR10445 (Exp: 4/19); Batch# DR10637 (Exp: 5/19); Batch# DR10646 (Exp: 5/19); Batch# DR10647 (Exp: 5/19); Batch# DR10725 (Exp: 7/19); Batch# DR10755 (Exp: 7/19); Batch# DR10811 (Exp: 9/19); Batch# DS10040 (Exp: 12/19); Batch# DS10041 (Exp: 12/19); Batch# DS10024 (Exp: 12/19); and Batch# DS10048 (Exp: 12/19).

Where was it sold?

Nationwide.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Wockhardt

All 2
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIIEnalapril Maleate Tablets recalled by WockhardtWockhardtPotency & AssayNationwide

Other Enalapril recalls

All 16